fda tirzepatide obesity says that the GLP-1 shortage is over FDA Approves Lilly's Zepbound™ (tirzepatide)

This is the common nausea patients experience on GLP-1 medications

Side Effects, Clinical Evidence, and What to Expect Last Updated June 2026 As tirzepatide continues to reshape the landscape of medical weight loss, one of the most common questions patients ask before starting treatment is straightforward and important: is tirzepatide safe for long-term use

Stroobandt et al., 1982

However, while tirzepatide demonstrated superior efficacy comparing with placebo, an increased risk of adverse events, particularly gastrointestinal symptoms, was observed

Eliminating food noise meant taking away my urges to snack when Im bored, random junk food cravings, and even anxiety around how much Ive eaten

6 Garrido-Castro AC, Lin NU, Polyak K